Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Dumbani, M."'
Autor:
Adhikary PP; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Idowu T; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Tan Z; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Hoang C; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Shanta S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Dumbani M; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany., Mappalakayil L; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Awasthi B; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Bermudez M; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.; Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany., Weiner J; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany., Beule D; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany., Wolber G; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany., Page BDG; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. brent.page@ubc.ca., Hedtrich S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. sarah.hedtrich@bih-charite.de.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany. sarah.hedtrich@bih-charite.de.; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. sarah.hedtrich@bih-charite.de.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany. sarah.hedtrich@bih-charite.de.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Dec; Vol. 16 (12), pp. 3247-3250.
Autor:
Schöpe PC; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Torke S; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Kobelt D; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Kortüm B; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Treese C; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Dumbani M; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Güllü N; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Walther W; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany., Stein U; Experimental and Clinical Research Center, Charité - Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. ustein@mdc-berlin.de.; German Cancer Consortium (DKTK), Berlin and German Cancer Research Center (DKFZ), Heidelberg, Germany. ustein@mdc-berlin.de.
Publikováno v:
Biomarker research [Biomark Res] 2024 Nov 23; Vol. 12 (1), pp. 146. Date of Electronic Publication: 2024 Nov 23.
Autor:
Adhikary PP; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Idowu T; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Tan Z; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Hoang C; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Shanta S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Dumbani M; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany., Mappalakayil L; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Awasthi B; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada., Bermudez M; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany.; Institute of Pharmaceutical and Medicinal Chemistry, Westfälische Wilhelms-Universität Münster, Münster, Germany., Weiner J; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany., Beule D; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany., Wolber G; Institute of Pharmacy, Freie Universität of Berlin, Berlin, Germany., Page BD; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. brent.page@ubc.ca., Hedtrich S; Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, Canada. sarah.hedtrich@bih-charite.de.; Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Germany Charité - Universitätsmedizin Berlin, Berlin, Germany. sarah.hedtrich@bih-charite.de.; Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. sarah.hedtrich@bih-charite.de.; Max-Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), 13125, Berlin, Germany. sarah.hedtrich@bih-charite.de.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2024 Jul; Vol. 16 (7), pp. 1630-1656. Date of Electronic Publication: 2024 Jun 14.
Publikováno v:
International Journal of Nanomedicine, Vol Volume 14, Pp 7861-7878 (2019)
Tony Bewersdorff,1 Alexandra Gruber,2 Murat Eravci,1 Malti Dumbani,1 Daniel Klinger,2 Andrea Haase1 1German Federal Institute for Risk Assessment (BfR), Department of Chemical and Product Safety, Berlin, Germany; 2Freie Universität Berlin, Institute
Externí odkaz:
https://doaj.org/article/c159323ffa504e39b90787a122145186
Autor:
Kobelt, D., Dahlmann, M., Dumbani, M., Güllü, N., Kortüm, B., Vílchez, M.E.A., Stein, U., Walther, W.
Metastasis represents the most lethal attribute of cancer and critically limits successful therapies in many tumor entities. The clinical need is defined by the fact that all cancer patients, who have or who will develop distant metastasis, will expe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=mdc______med::4a3c106f75a04394639ed11683992115
http://edoc.mdc-berlin.de/19033/1/19033oa.pdf
http://edoc.mdc-berlin.de/19033/1/19033oa.pdf
Autor:
Basti A; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute for Theoretical Biology, 10115 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Medical Department of Hematology, Oncology, and Tumor Immunology, Molecular Cancer Research Center, 13353 Berlin, Germany.; Institute for Systems Medicine, Faculty of Human Medicine, MSH Medical School Hamburg, 20457 Hamburg, Germany., Malhan D; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute for Theoretical Biology, 10115 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Medical Department of Hematology, Oncology, and Tumor Immunology, Molecular Cancer Research Center, 13353 Berlin, Germany.; Institute for Systems Medicine, Faculty of Human Medicine, MSH Medical School Hamburg, 20457 Hamburg, Germany., Dumbani M; Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine Berlin in the Helmholtz-Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Dahlmann M; Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine Berlin in the Helmholtz-Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Stein U; Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine Berlin in the Helmholtz-Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Relógio A; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute for Theoretical Biology, 10115 Berlin, Germany.; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Medical Department of Hematology, Oncology, and Tumor Immunology, Molecular Cancer Research Center, 13353 Berlin, Germany.; Institute for Systems Medicine, Faculty of Human Medicine, MSH Medical School Hamburg, 20457 Hamburg, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Jul 16; Vol. 14 (14). Date of Electronic Publication: 2022 Jul 16.
Autor:
Kobelt D; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Dahlmann M; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Dumbani M; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Güllü N; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Kortüm B; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Vílchez MEA; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany., Stein U; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Walther W; Department Translational Oncology of Solid Tumors, Experimental and Clinical Research Center, Charité University Medicine Berlin and Max-Delbrück-Center for Moelcular Medicine in the Helmholtz Association, Robert-Rössle-Straße 10, 13125 Berlin, Germany.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jun 03; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 03.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Erdem, Müge1 (AUTHOR) dennis.kobelt@epo-berlin.com, Lee, Kyung Hwan1 (AUTHOR), Hardt, Markus1 (AUTHOR), Regan, Joseph L.2,3 (AUTHOR), Kobelt, Dennis1,4 (AUTHOR), Walther, Wolfgang1 (AUTHOR), Mokrizkij, Margarita1 (AUTHOR), Regenbrecht, Christian5 (AUTHOR), Stein, Ulrike1,4 (AUTHOR) ustein@mdc-berlin.de
Publikováno v:
Cancers. Feb2024, Vol. 16 Issue 3, p604. 19p.
Publikováno v:
Biomedicines; Oct2024, Vol. 12 Issue 10, p2312, 32p